lobbying_activities: 1071579

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1071579	1f577934-986d-4181-8f9f-9bec69e207df	Q1	HOLLAND & KNIGHT LLP	18466	ALLIANCE FOR REGENERATIVE MEDICINE	2011	first_quarter	SCI	Advocate for funding for regenerative medicine companies; Advocate for NIH funding for regenerative medicine research. Advocate for new regulations re: approval of regenerative medicine products. Advocate for funding for the FDA. Work with NIST on standards for reginerative medicine products. Advocate for assessment of federal regenerative medicine activities. Draft legislation to support regenerative medicine research and development.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE	80000		0	0	2011-04-06T12:52:20.593000-04:00